Ran Kornowski, Brad Oldemeyer, Mitusnobu Kitamura, Luke Oakley, Tomoki Ochiai, Tarun Chakravarty, Mamoo Nakamura, Philip Ruile, Florian Deuschl, Daniel Berman, Thomas Modine, Stephan Ensminger, Uri Landes, Rudiger Lange, James M McCabe, Mathew R Williams, Brian Whisenant, Victoria Delgado, Eric Van Belle, Lars Sondergaard, Bernard Chevalier, Michael Mack, Martin B Leon, Raj R Makkar, Tobias Shmidt, Jeroen J Bax, Vasilis Babaliaros, Sung-Han Yoon, Won-Keun Kim, Abhijeet Dhoble, Stephan Milhorini Pio, Hasan Jilaihawi, Thomas Pilgrim, Ole De Backer, Sabine Bleiziffer, Flavien Vincent, Stephan Windecker, Christian Butter, Norihiko Kamioka, Lena Eschenbach, Matthias Renker, Masahiko Asami, Mohamad Lazkani, Buntaro Fujita, Antoinette Birs, Marco Barbanti, Ashish Pershad
Journal: Journal of the American College of Cardiology 2021;76(9):1018-1030
PMID: 32854836
BACKGROUND
Bicuspid aortic stenosis accounts for almost 50% of patients undergoing surgical aortic valve replacement in the younger patients. Expanding the indication of transcatheter aortic valve replacement (TAVR) toward lower-risk and younger populations will lead to increased use of TAVR for patients with bicuspid aortic valve (BAV) stenosis despite the exclusion of bicuspid anatomy in all pivotal clinical trials.
OBJECTIVES
This study sought to evaluate the association of BAV morphology and outcomes of TAVR with the new-generation devices.
METHODS
Patients with BAV confirmed by central core laboratory computed tomography (CT) analysis were included from the international multicenter BAV TAVR registry. BAV morphology including the number of raphe, calcification grade in raphe, and leaflet calcium volume were assessed with CT analysis in a masked fashion. Primary outcomes were all-cause mortality at 1 and 2 years, and secondary outcomes included 30-day major endpoints and procedural complications.
RESULTS
A total of 1,034 CT-confirmed BAV patients with a mean age of 74.7 years and Society of Thoracic Surgeons score of 3.7% underwent TAVR with contemporary devices (n = 740 with Sapien 3; n = 188 with Evolut R/Pro; n = 106 with others). All-cause 30-day, 1-year, and 2-year mortality was 2.0%, 6.7%, and 12.5%, respectively. Multivariable analysis identified calcified raphe and excess leaflet calcification (defined as more than median calcium volume) as independent predictors of 2-year all-cause mortality. Both calcified raphe plus excess leaflet calcification were found in 269 patients (26.0%), and they had significantly higher 2-year all-cause mortality than those with 1 or none of these morphological features (25.7% vs. 9.5% vs. 5.9%; log-rank p < 0.001). Patients with both morphological features had higher rates of aortic root injury (p < 0.001), moderate-to-severe paravalvular regurgitation (p = 0.002), and 30-day mortality (p = 0.016).
CONCLUSIONS
Outcomes of TAVR in bicuspid aortic stenosis depend on valve morphology. Calcified raphe and excess leaflet calcification were associated with increased risk of procedural complications and midterm mortality. (Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry; NCT03836521).
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Full Text Sources:
Medical:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.